Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine if thymectomy combined with prednisone therapy is
more beneficial in treating non-thymomatous myasthenia gravis than prednisone therapy alone.
Phase:
Phase 3
Details
Lead Sponsor:
University of Alabama at Birmingham
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)